Relativity Acquisition Corp.
RACYU
NASDAQ Global Market12.99
USD
+0.04
- -
CIK
0001860484
ISIN
US75944B2051
CUSIP
75944B205
Return %
Stock
S&P500
1Y
- -
18.21
3Y
29.64
64.38
5Y
29.64
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Tarek Khalil Tabsh
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 3753 Howard Hughes Parkway Las Vegas NV United States of America 89169
- IPO Date
- Feb 11, 2022
- CIK
- 0001860484
- Website
- relativityacquisitions.com
- Similar Companies
- Business
- Relativity Acquisition Corp. Relativity Acquisition Corp. is a blank check company whose sole purpose is to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses; it conducts no significant operations prior to completing such a transaction. The company offers no products or services itself but maintains funds from its initial public offering, conducted in February 2022 raising $143.75 million, placed in trust for deployment in a target acquisition. While initially focused on the cannabis industry and related sectors including consumer packaged goods, health and wellness, technology, pharmaceuticals, manufacturing, distribution, logistics and brand management—all compliant with applicable laws—it pursues opportunities in any industry or geographic location. Relativity Acquisition Corp., incorporated in Delaware on April 13, 2021 and headquartered at 3753 Howard Hughes Parkway, Suite 200, Las Vegas, Nevada 89169, operates principally in the United States with a global target search scope. In recent developments, Relativity Acquisition Corp. entered into a definitive business combination agreement on March 4, 2025, with Instinct Brothers Co., Ltd., a Japanese vertically integrated regenerative medicine firm; the transaction, valuing the combined entity at a pro forma enterprise value of approximately $242 million assuming no further redemptions, contemplates Instinct Brothers becoming a wholly owned subsidiary with the post-combination company renamed Instinct Bio Technical Company Inc. and listed publicly. The proposed merger, targeting closure in Q3 2025 subject to stockholder approval and customary conditions, marks a strategic shift into the healthcare sector with an Asia geographic focus, following the mutual termination in May 2024 of a prior business combination agreement with SVES, an off-price apparel distributor that had been announced in February 2023 with a $707.25 million enterprise value.
Cannabis-Focused SPAC Relativity Acquisition Corp. Prices Its Initial Public Offering At $125 Million